Necrosis and apoptosis

39,944views

Necrosis and apoptosis

Block 2

Block 2

Pentose phosphate pathway
Diabetes mellitus
Disorders of carbohydrate metabolism: Pathology review
Amino acid metabolism
Disorders of amino acid metabolism: Pathology review
Dyslipidemias: Pathology review
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Diabetes mellitus (Type 2): Clinical sciences
Fatty acid synthesis
Wernicke-Korsakoff syndrome
Alcohol-induced hepatitis: Clinical sciences
Diabetes mellitus: Clinical
Diabetes mellitus (Type 1): Clinical sciences
Fetal alcohol syndrome
Diabetes mellitus: Pathology review
Alcohol use disorder
Alcohol-associated liver disease
Enterococcus
Staphylococcus epidermidis
Mycobacterium tuberculosis (Tuberculosis)
Neisseria gonorrhoeae
Corynebacterium diphtheriae (Diphtheria)
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Vitamin D
Klebsiella pneumoniae
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Streptococcus viridans
Clostridium perfringens
Chlamydia trachomatis
Staphylococcus saprophyticus
Staphylococcus aureus
Mycobacterium leprae
Clostridium botulinum (Botulism)
Bacillus anthracis (Anthrax)
Actinomyces israelii
Clostridium tetani (Tetanus)
Streptococcus agalactiae (Group B Strep)
Bacillus cereus (Food poisoning)
Listeria monocytogenes
Pseudomonas aeruginosa
Nocardia
Haemophilus influenzae
Neisseria meningitidis
Treponema pallidum (Syphilis)
Human papillomavirus
Herpes simplex virus
Neuraminidase inhibitors
Human herpesvirus 6 (Roseola)
Borrelia burgdorferi (Lyme disease)
Adenovirus
Yersinia pestis (Plague)
Rhinovirus
Rubella virus
Influenza virus
Mumps virus
Measles virus
Human herpesvirus 8 (Kaposi sarcoma)
Herpesvirus medications
Plasmodium species (Malaria)
Coxiella burnetii (Q fever)
Ehrlichia and Anaplasma
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Anthelmintic medications
Antimalarials
Trypanosoma cruzi (Chagas disease)
Francisella tularensis (Tularemia)
Candida
Anti-mite and louse medications
Miscellaneous antifungal medications
Azoles
Cytokines
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Hyper IgM syndrome
Leukocyte adhesion deficiency
Chronic granulomatous disease
X-linked agammaglobulinemia
Wound healing
Complement deficiency
Inflammation
Pulmonary corticosteroids and mast cell inhibitors
Selective immunoglobulin A deficiency
Necrosis and apoptosis
Ischemia
Wiskott-Aldrich syndrome
Immunodeficiencies: Clinical
Non-corticosteroid immunosuppressants and immunotherapies
Intrinsic hemolytic normocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Blood groups and transfusions
Macrocytic anemia: Pathology review
Cytomegalovirus infection after transplant (NORD)
Glucocorticoids
Blood products and transfusion: Clinical
Acute intermittent porphyria
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Aplastic anemia
Sideroblastic anemia
Microcytic anemia: Pathology review
Erythropoietin
Post-transplant lymphoproliferative disorders (NORD)
Platelet disorders: Pathology review
Thrombotic thrombocytopenic purpura
Neonatal jaundice: Clinical
Jaundice: Clinical
Mixed platelet and coagulation disorders: Pathology review
Von Willebrand disease
Immune thrombocytopenia
Hemolytic-uremic syndrome
Extrinsic hemolytic normocytic anemia: Pathology review
Jaundice
Iron deficiency anemia
Anemia: Clinical
Graft-versus-host disease
Iron deficiency anemia: Clinical sciences
Autoimmune hemolytic anemia
Severe chronic neutropenia (NORD)
Anemia of chronic disease: Year of the Zebra
Jaundice: Pathology review
Blood transfusion reactions and transplant rejection: Pathology review
Anemia of chronic disease
Non-hemolytic normocytic anemia: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Protein synthesis inhibitors: Aminoglycosides
Nucleotide metabolism
Adenosine deaminase deficiency
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Gout
Gout and pseudogout: Pathology review
Lesch-Nyhan syndrome
Gout: Clinical sciences
Oncogenes and tumor suppressor genes
Anti-tumor antibiotics
Blood histology
DNA synthesis inhibitors: Metronidazole
Deep vein thrombosis
Disseminated intravascular coagulation
Factor V Leiden
Protein C deficiency
Protein S deficiency
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Antithrombin III deficiency
Heparin-induced thrombocytopenia
Antiphospholipid syndrome
Hemophilia
Hemophilia: Year of the Zebra
Protease inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Hepatitis medications
HIV and AIDS: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Mechanisms of antibiotic resistance
Coagulation disorders: Pathology review
Integrase and entry inhibitors
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Lymphomas: Pathology review
Chronic leukemia
Acute leukemia
Non-Hodgkin lymphoma
Polycythemia vera (NORD)
Myelodysplastic syndromes
Hodgkin lymphoma
Essential thrombocythemia (NORD)
Waldenstrom macroglobulinemia
Multiple myeloma: Clinical sciences
Mastocytosis (NORD)
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Spleen histology
Myelofibrosis (NORD)
Lymphoma: Clinical
Varicella zoster virus
Coxsackievirus
Congenital TORCH infections: Pathology review
Streptococcus pyogenes (Group A Strep)
Lyme disease: Clinical sciences
Cortisol
Hematopoietic medications
Parvovirus B19
HIV (AIDS)
Zika virus

Transcript

Watch video only

Generally speaking, cells have two ways to die. One way is by apoptosis, which is a form of programmed cell death. The second way is by necrosis, which is when cells die due to injury or disease. Overall, apoptosis occurs much more often than necrosis. One example is when old skin cells undergo apoptosis and get replaced by new skin cells. Another example is in our hands and feet during fetal development. Initially, human hands and feet look like duck’s feet, with webs of skin connecting the fingers. But the cells in the webbing undergo apoptosis, and that allows us to form individual digits that allow us to pick our nose and play the piano. In contrast, necrosis occurs less frequently. An example of necrosis is when a blood vessel that feeds an area of the body, say the big toe, becomes blocked and can’t deliver oxygen and nutrients to the cells like usual, it causes ischemia, and the cells die. As a result, the tissues of the toe will turn a nasty shade of black, signaling necrosis.

In apoptosis, there are two activating mechanisms - the intrinsic pathway, also called the mitochondrial pathway, and the extrinsic pathway, also called the death receptor pathway.

The intrinsic pathway occurs when a cell is exposed to stress like radiation, hypoxia, or low oxygen, a high intracellular concentration of calcium ions, or oxidative stress, which is where reactive molecules with unpaired electrons called free radicals steal electrons from nearby molecules.

These stressors cause two intracellular proteins, Bax and Bak, to move from the cytosol to the mitochondria. Once in the mitochondria, Bax and Bak pierce the outer mitochondrial membrane making it porous and leaky. This allows two additional proteins, called SMACS and cytochrome C, to spill into the cytosol. SMACS binds to proteins that normally inhibit apoptosis and deactivates them. Meanwhile, cytochrome C binds to both ATP - the main form of intracellular energy - as well as an enzyme called Apaf-1. Together, cytochrome C and Apaf-1 combine to form a large protein complex called an apoptosome.

The Apaf-1 portion of the apoptosome then cleaves an enzyme called pro-caspase 9 into its active form, caspase-9. Caspase 9 then goes on to activate caspase-3, and caspase-3 goes on to activate other caspases - like a chain event. Eventually, this caspase cascade leads a cell to commit apoptosis.

That’s because these caspases cleave the proteins that make up the cell’s nucleus, organelles, and cytoskeleton - a bit like a ninja sabotaging a bridge by removing its nuts and bolts.

This destroys the cytoskeleton, as well as the proteins that anchor the cytoskeleton to the cell membrane. As a result, the cell membrane starts to develop blebs - or bulges in the cell membrane. The blebs are structurally weak, so they start to break off from the cell membrane, eventually forming small apoptotic bodies that are eaten by neighboring phagocytes. At the same time, the apoptotic cell releases anti-inflammatory signals, thereby preventing the recruitment of other immune cells from the blood and preventing tissue inflammation. So apoptosis is a neat process that conveniently recycles the organic contents of the dead cell.

Now, when the signals from apoptosis come from outside the cell - it’s called the extrinsic pathway. One example is when a nearby macrophage recognizes an old cell, a pathogenic cell, or a cell that has completed its task. In these situations, a macrophage can initiate apoptosis by releasing tumor necrosis factor alpha or TNF-alpha, a cell-signaling protein,

that binds to very appropriately named death receptors on the target cell membrane, one example being tumor necrosis factor receptor 1. The cytosolic end of this receptor, dives deep inside the cell, and it’s called the death domain. When the TNF-alpha binds to the tumor necrosis factor receptor 1, the death domain changes its shape and is able to bind to two proteins. One is called Fas-associated protein with death domain or FADD and the other is called take a deep breath here

Tumor necrosis factor receptor type 1-associated DEATH domain protein or TRADD.

So the death receptor, FADD, and TRADD come together to form a multi-complex protein called... wait for it... the death-inducing signaling complex or DISC. Once everything is together, DISC cleaves pro-caspase-8 into caspase-8, which in turn activates caspase-3, and caspase-3 goes on to activate other caspases. This initiates the caspase cascade that commits the cell to apoptosis. After that, the process of apoptosis unfolds just like in the intrinsic pathway.

Now in addition to macrophages, if a cytotoxic T cell detects that a cell is expressing foreign antigens, the T cell will express a protein on its membrane called Fas ligand which binds to a death receptor on the target cell called the first apoptosis signal receptor - or Fas receptor. Similar to the death domain of tumor necrosis factor receptor 1, the Fas receptor protein also has its very own death domain that can bind to FADD to form DISC. As before, DISC activates pro-caspase-8 into caspase-8 and that triggers the caspase cascade which leads to apoptosis.

Alright, let’s switch gears and take a look at necrosis, which can be triggered by external factors like an infection, or extremely hot or cold temperatures; as well as internal factors like tissue ischemia. Now, there are three main types of necrosis called primary, secondary, and regulated necrosis.

Primary necrosis, also known as accidental necrosis or oncotic necrosis, typically occurs when ischemia disrupts the normal functioning of mitochondria. As a result, the cell is unable to synthesize ATP, causing all ATP-dependent cellular processes to stop working, including the ionic pumps that regulate the flow of ions in and out of the cell. Without functioning ion pumps, sodium starts to flow into the cell, and it's followed by water.

This causes the cell to swell up like a balloon. This process of cell swelling is called oncosis. Soon, the cell bursts and spills its internal contents and small molecules called damage-associated molecular patterns into the surroundings.

These molecules trigger the inflammatory response and attract nearby immune cells to release substances like proteases, which are enzymes that degrade proteins, and reactive oxygen species, which are unstable molecules that can damage other cells. If this inflammatory process occurs among enough cells, it can destroy the tissue, and if it happens on a massive level it can lead to organ dysfunction. Now it turns out that primary necrosis comes in a few different flavors.

First, there’s coagulative necrosis, which occurs when a tissue becomes hypoxic - has low levels of oxygen - most commonly due to ischemia.

Key Takeaways

Necrosis is a type of cell death that occurs when cells are damaged by external factors like an infection, as well as internal factors like tissue ischemia. There are six types of necrosis: coagulative and gangrenous necrosis, which happen to hypoxic tissues; liquefactive necrosis, which happens because of hydrolytic enzymes; caseous necrosis - like in tuberculosis; fat necrosis, which happens when fatty acids spill outside adipose cells, like during trauma, and finally fibrinoid necrosis - which is caused by fibrin deposits, like in malignant hypertension.

Apoptosis, on the other hand, is a programmed cell death that occurs when the body needs to get rid of damaged or unnecessary cells. Apoptosis occurs due to intrinsic and extrinsic pathways. With apoptosis, white blood cells come in and clean up the dead tissue, so this is a neat way for cells to die.

Sources

    1. FRCPath, K. V. M. M., Mbbs, A. A. K., & Md, J. A. C., PhD. (2020). Robbins & Cotran Pathologic Basis of Disease (Robbins Pathology) (10th ed.). Elsevier. ISBN 9780323531139 

    1. Hammer, G., & McPhee, S. (2018). Pathophysiology of Disease: An Introduction to Clinical Medicine 8E (8th ed.). McGraw Hill / Medical. ISBN 978-1260026504 

    1. Jameson, L. J., Fauci, A., Kasper, D., Hauser, S., Longo, D., & Loscalzo, J. (2018). Harrison’s Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2) (20th ed.). McGraw Hill / Medical. ISBN 978-1264268504 

    1. Park, M. Y., Ha, S. E., Vetrivel, P., Kim, H. H., Bhosale, P. B., Abusaliya, A., & Kim, G. S. (2021). Differences of Key Proteins between Apoptosis and Necroptosis. BioMed research international, 2021, 3420168. https://doi.org/10.1155/2021/3420168 

    1. Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019). Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease. Physiological reviews, 99(4), 1765–1817. https://doi.org/10.1152/physrev.00022.2018